JAMA: Med-school officials risk conflicts by serving on pharma boards | PharmaBoardroom
written on 02.04.2014
Tags:
,

JAMA: Med-school officials risk conflicts by serving on pharma boards

TAGS: ,

Much has been made recently over the potential conflicts of interest that arise when doctors take speaking fees from pharma companies. But as a new report suggests, some companies are shelling out a whole lot more to keep medical school and hospital leaders on their boards–where conflicts-of-interest could be much further-reaching.

Latest Report